USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 146 filers reported holding USANA HEALTH SCIENCES INC in Q2 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,344,681 | -2.5% | 244,719 | +4.9% | 0.00% | 0.0% |
Q2 2023 | $14,710,257 | +4.2% | 233,348 | +4.0% | 0.00% | 0.0% |
Q1 2023 | $14,117,213 | +117337.9% | 224,439 | -0.7% | 0.00% | 0.0% |
Q4 2022 | $12,021 | -99.9% | 225,960 | +1.5% | 0.00% | 0.0% |
Q3 2022 | $12,479,000 | -20.8% | 222,650 | +2.3% | 0.00% | 0.0% |
Q2 2022 | $15,749,000 | -2.9% | 217,656 | +6.6% | 0.00% | 0.0% |
Q1 2022 | $16,226,000 | -24.4% | 204,240 | -3.6% | 0.00% | -33.3% |
Q4 2021 | $21,449,000 | +9.9% | 211,952 | +0.1% | 0.00% | 0.0% |
Q3 2021 | $19,518,000 | -12.5% | 211,699 | -2.8% | 0.00% | 0.0% |
Q2 2021 | $22,311,000 | +11.9% | 217,820 | +6.6% | 0.00% | 0.0% |
Q1 2021 | $19,940,000 | +37.2% | 204,309 | +8.4% | 0.00% | +50.0% |
Q4 2020 | $14,537,000 | +6.5% | 188,551 | +1.7% | 0.00% | -33.3% |
Q3 2020 | $13,653,000 | -6.8% | 185,379 | -7.0% | 0.00% | 0.0% |
Q2 2020 | $14,642,000 | +16.0% | 199,414 | -8.8% | 0.00% | 0.0% |
Q1 2020 | $12,623,000 | -61.5% | 218,544 | -47.6% | 0.00% | 0.0% |
Q4 2019 | $32,756,000 | +130.9% | 417,024 | +101.0% | 0.00% | 0.0% |
Q3 2019 | $14,189,000 | -12.8% | 207,481 | +1.3% | 0.00% | -25.0% |
Q2 2019 | $16,273,000 | -11.0% | 204,875 | -6.0% | 0.00% | -20.0% |
Q1 2019 | $18,276,000 | -61.0% | 217,920 | -45.3% | 0.01% | -28.6% |
Q4 2018 | $46,860,000 | +108.4% | 398,042 | +113.3% | 0.01% | +16.7% |
Q3 2018 | $22,491,000 | +35.8% | 186,576 | +29.9% | 0.01% | +20.0% |
Q2 2018 | $16,562,000 | +79.1% | 143,652 | +33.5% | 0.01% | +66.7% |
Q1 2018 | $9,245,000 | +16.6% | 107,638 | +0.5% | 0.00% | 0.0% |
Q4 2017 | $7,928,000 | +45.2% | 107,080 | +13.2% | 0.00% | +50.0% |
Q3 2017 | $5,459,000 | -22.2% | 94,612 | -13.6% | 0.00% | -33.3% |
Q2 2017 | $7,017,000 | -1.9% | 109,474 | -11.9% | 0.00% | 0.0% |
Q1 2017 | $7,154,000 | +6.1% | 124,211 | +12.7% | 0.00% | 0.0% |
Q4 2016 | $6,743,000 | +0.4% | 110,193 | +127.1% | 0.00% | 0.0% |
Q3 2016 | $6,713,000 | +15.6% | 48,524 | -6.9% | 0.00% | 0.0% |
Q2 2016 | $5,808,000 | -20.2% | 52,131 | -13.1% | 0.00% | -25.0% |
Q1 2016 | $7,281,000 | -20.9% | 59,968 | -16.8% | 0.00% | -20.0% |
Q4 2015 | $9,205,000 | -5.6% | 72,061 | -1.0% | 0.01% | -16.7% |
Q3 2015 | $9,750,000 | -7.7% | 72,753 | -5.9% | 0.01% | 0.0% |
Q2 2015 | $10,566,000 | +20.7% | 77,323 | -1.9% | 0.01% | +20.0% |
Q1 2015 | $8,755,000 | +11.7% | 78,800 | +3.1% | 0.01% | 0.0% |
Q4 2014 | $7,841,000 | +146.5% | 76,445 | +77.0% | 0.01% | +150.0% |
Q3 2014 | $3,181,000 | -5.7% | 43,186 | -0.0% | 0.00% | 0.0% |
Q2 2014 | $3,375,000 | -10.3% | 43,203 | -13.5% | 0.00% | -33.3% |
Q1 2014 | $3,763,000 | +25.3% | 49,962 | +25.7% | 0.00% | +50.0% |
Q4 2013 | $3,003,000 | +0.8% | 39,741 | +15.8% | 0.00% | 0.0% |
Q3 2013 | $2,979,000 | -5.4% | 34,322 | -21.1% | 0.00% | -33.3% |
Q2 2013 | $3,148,000 | – | 43,493 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
RQSI Ltd | 3,937 | $404,000 | 0.38% |
CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |